Lv11
20 积分 2024-01-07 加入
SMARCA4: Current status and future perspectives in non-small-cell lung cancer
1小时前
待确认
Immunotherapy-based combinations in metastatic NSCLC
1小时前
已完结
Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer
1小时前
已完结
Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies
28天前
已完结
Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC)
1个月前
已完结
Refining neoadjuvant immunotherapy for resectable lung cancer
1个月前
已完结
Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancer
2个月前
已完结
Lung cancer screening
2个月前
已完结
MAIT cells are associated with responsiveness to neoadjuvant immunotherapy in COPD‐associated NSCLC
2个月前
已完结
Survival and pulmonary function in stage IA non‐small cell lung cancer after sublobar resection versus lobectomy: An updated meta‐analysis
2个月前
已完结
皖公网安备34019202002308
